International Excellence Team To Work On Infectious Disease At The Gulbenkian Science Institute, In PortugalJanuary 31, 2005The Gulbenkian Science Institute (IGC), in Portugal, is to host one of the 20 excellence teams approved by the European Commission in the 2004 call. The team, led by IGC researcher Gabriela Gomes, has been awarded a grant of approximately one million and nine hundred thousand euro, to be used over a period of four years. The scientists on the team will develop mathematical models to be applied in the control of recurrent infections, such as malaria and tuberculosis. The work is being undertaken in collaboration with experimental scientists, public health teams and the pharmaceutical industry. The excellence team is made up of researchers from the United Kingdom, France, Portugal, Kenya, Australia and the United States, bringing together world renowned expertise in mathematical and computational modelling, data analysis, ecology and evolution of infectious diseases, and epidemiology. The aim is to respond successfully to the present day challenge of developing and deploying multidisciplinary strategies to fight recurrent and persistent infections. This team's work will lead to a better understanding of some of the unresolved inconsistencies in the transmission of infections, such as the variable efficacy of the BCG vaccine against tuberculosis, or the effect on malaria prevention of mosquito nets. Based on the concept of reinfection threshold, first introduced by Gabriela Gomes, it will be possible to model and manipulate several of the factors thought to play a role in controlling these diseases: vaccination, sanitation and therapeutics, amongst others.
According to Gabriela Gomes, the team will strengthen existing collaborations and pursue new ones with experimental research groups and public health teams, both in Portugal and abroad. Two PhD studentships are available, within the team. This proposal is one of only 20 approved by the Commission, out of 298 proposals submitted for evaluation. According to Ant'³nio Coutinho, this award is yet a further example of the success of the IGC in its mission to be a host institution where researchers may autonomously propose and develop award-winning projects, with the added value of bringing internationally reputed scientists to the country, to develop a novel field and train future scientists. Instituto Gulbenkian de CiÙncia (IGC) | |||||||||||||||||||||
|
Related Malaria Current Events and Malaria News Articles Scientists decode genome of parasite that causes relapsing malaria Scientists have deciphered the complete genetic sequence of the parasite Plasmodium vivax, the leading cause of relapsing malaria, and compared it with the genomes of other species of malaria parasites. Common insecticide can decimate tadpole populations The latest findings of a University of Pittsburgh-based project to determine the environmental impact of routine pesticide use suggests that malathion--the most popular insecticide in the United States--can decimate tadpole populations by altering their food chain, according to research published in the Oct. 1 edition of Ecological Applications. Nanotech and synbio: Americans don't know what's coming A groundbreaking poll finds that almost half of U.S. adults have heard nothing about nanotechnology, and nearly nine in 10 Americans say they have heard just a little or nothing at all about the emerging field of synthetic biology, according to a new report released by the Project on Emerging Nanotechnologies (PEN) and Peter D. Hart Research. New way to make malaria medicine also first step in finding new antibiotics University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive. New UNC laboratory to help track and control tropical diseases The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods. Hidden infections crucial to understanding, controlling disease outbreaks Scientists and news organizations typically focus on the number of dead and gravely ill during epidemics, but research at the University of Michigan suggests that less dramatic, mild infections lurking in large numbers of people are the key to understanding cycles of at least one potentially fatal infectious disease: cholera. New insights could lead to a better pneumococcal vaccine Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). Purifying parasites with light Researchers have developed a clever method to purify parasitic organisms from their host cells, which will allow for more detailed proteomic studies and a deeper insight into the biology of organisms that cause millions of cases of disease each year. 'Dodgy dossier' partly to blame for failure of war against malaria in the tropics The war against malaria in tropical countries was fought and lost in the 20th Century on the basis of faulty intelligence, a 'dodgy dossier' which argued that the same methods used to tackle the disease in temperate countries would also work in the tropics. Best way to treat malaria: Avoid using same drug for everyone, scientists say A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||